Table 1

General study characteristics

ReferenceSample size, baseline BMI (kg/m²)Age (years), female (%)
male (%)
Duration (years)SFA/PUFA/MUFA/trans FA (as indicated by the investigators)LA, ALAFish consumption adviceTF, cholesterolInclusion criteriaSupplementEnergy amount (end of the study)Outcomes
Ball et al (1965)20*264
nd
<65
100%
4I: 9%, 5%, 8%
C: 16–18%, 7%, 15%
I: 4.5%
C: 6.3%
I: 22%, 330 mg
C: 47%, 650–750 mg
Post-MI2030
2360
ACM, CVM, CVE, MI
Burr et al (1989)27203356.6
100%
2I: 11.3%, 8.9%, 12.1%
C: 15%, 6.4%, 13.6%
I: 8.01%
C: 5.76%
I: 32.3%
C: 35%, 650–750 mg
Post-MIndACM, CVM, CVE
de Lorgeril et al (1994)24605
nd
53.5
9.25%
90.75%
4I: 8.3%, 8.2%, 12.9%
C: 11.7%, 11.4%, 10.3%
I: 3.6%, 0.81%
C: 5.3%, 0.27%
yesI: 30.5%, 217
C: 32.7%, 318 mg
Post-MII: Canola oil based margarine1928
2140
ACM, CVM, CVE
Howard et al (2006)322277
29.1
62.3
100%
6I: 9.5%, 6.1%, 10.8%, 1.8%
C: 12.4%, 7.5%, 14.2%, 2.4%
I: 5.49%
C: 6.75%
I: 28.8%, 193.6 mg
C: 37%, 243.5 mg
Post-MI, stroke, CABG or PCI1431
1546
CVM, CVE, MI, stroke
Leren et al (1970)21*412
nd
56.25
100%
5I: 8.5%, 20.7%, 10.1%
C: 16–18%, 7%, 15%
I: 14.8%, 2.7%
C: 3.3%, nd
yesI: 39%; 264 mg
C: 40%, 650–750 mg
Post-MII: 75 g Soya-bean oil2380ACM, CVM, CVE, MI
MRC (1968)26393
nd
53.5
100%
5I: 11.3%, 20.4%, 14.3%
C: 26.4%, 4.4%, 12.2%
I: 16.3%, 2.3%
C: 3.96
I: 46%
C: 43%, 650–750 mg
Post-MII: 85 g soya-bean oil nd
nd
ACM, CVM, CVE, MI
Michalsen et al (2006)29101
26.55
59.4
23%
77%
1I: 10.1%, 6.1%, 10.6%
C: 13%, 7.4%, 12.2%
I: 4.8%, 0.72%
C: 6.2%, 0.7%
yesI: 32.2%, 251
C: 35.2%, 265 mg
CAD verified by coronary angiography2241
2237
Rose et al (1965)*2280
nd
<70
100%
2I: instructed to avoid fried foods, fatty meats, sausages, pastry, ice-cream, cheese, cakes, butter, milk, eggs restricted
I-olive: 11.7%, 8.7%, 26%
I-corn: 14%, 21.85%, 14.9%
C: no advice on dietary fat
C: 16–18%, 7%, 7%
I-olive: 8.2%, 0.28%
I-corn: 19.7%, 0.07%
C: 6.3%
I-olive: 46.2%
I-corn: 50.5%
C: 32.5%
Post-MI, angina pectorisI: 80 g olive oil;
80 g corn oil
2045
2070
1933
ACM, CVM, CVE, MI
Singh et al (1992)31406
23.8
51.25
12%
88%
1I: 7.2%, 8.6%, 8%
C: 10.8%, 7%, 10.2%
I: 7.74%
C: 6.3%
yesI: 23.8%
C: 28%
Post-MI, unstable angina pectoris1810
1940
ACM, CVM, CVE, MI
Sondergaard et al (2003)30131
nd
62.5
30%
70%
1I: 10.3%, 7.5%, 8.4%
C: 12%, 6.8%, 10.1%
I: 6.75%
C: 6.3%
yesI: 26.2%
C: 28.9%
Post-MI, stable/unstable angina pectoris1520
1550
Watts et al (1992)2890
26.25
51.4
100%
3I: 8–10%, 8%, 10%, 1.08%
C: 17%, 5.2%,14.8%,, 1.8%
I: 5%, 0.32%
C: 3.9%, 0.41%
I: 27%
C: 37%
Angina pectoris ndACM, CVM, CVE, MI
Woodhill et al (1978)25
Ramsden et al (2013)33
458
nd
49
100%
5I: 9.8%, 15.2%, 11.5%
C: 13.5%, 8.9%, 13.8%
I: 15%, nd
C: 8%, nd
I: 38.3%, 248
C: 38.1%, 342
Post-MI, angina pectoris, coronary insufficiency2289
2191
ACM, CVM, CVE
  • *SFA, MUFA and PUFA for study control groups were imputed based on average background dietary intakes in similar populations of the Diet Heart Study control group of 1968.26

  • ACM, all-cause mortality; ALA, α-linolenic acid; BMI, body mass index; C, control; CABG, coronary artery bypass graft ,CAD, coronary artery disease; CVE, cardiovascular events; CVM, cardiovascular mortality; FA, fatty acids; HDL-C, high-density lipoprotein cholesterol; I, intervention; LA, linoleic acid; LDL-C, low-density lipoprotein cholesterol; MI, myocardial infarction; MUFA, monounsaturated fat; nd, no data; PCI, percutaneous coronary intervention; PUFA, polyunsaturated fat; SFA, saturated fat; TC, total cholesterol; TF, total fat; TG, triacylglycerols.